BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grover S, Sahoo S. Treatment of Clozapine Nonresponders. Curr Treat Options Psych 2019;6:32-63. [DOI: 10.1007/s40501-019-0166-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Grover S, Sarkar S, Sahoo S. Augmentation strategies for clozapine resistance: a systematic review and meta-analysis. Acta Neuropsychiatr 2023;35:65-75. [PMID: 36380513 DOI: 10.1017/neu.2022.30] [Reference Citation Analysis]
2 Grover S, Kathiravan S. Clozapine research from India: A systematic review. Asian J Psychiatr 2023;79:103353. [PMID: 36493690 DOI: 10.1016/j.ajp.2022.103353] [Reference Citation Analysis]
3 Dubatova IV, Antsyborov LA, Kheigetian AF, Antsyborov AV. “Golden Shot” in the Treatment and Diagnosis of Schizophrenia: Psychiatrists or Neuroscientists? ISci 2021. [DOI: 10.21661/r-555399] [Reference Citation Analysis]
4 Sangüesa E, Cirujeda C, Concha J, Padilla PP, Ribate MP, García CB. Implementation of pharmacogenetics in a clozapine treatment resistant patient: a case report. Pharmacogenomics 2019;20:871-7. [DOI: 10.2217/pgs-2019-0074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]